78 related articles for article (PubMed ID: 17662987)
1. Inhibition of non-Ras protein farnesylation reduces in-stent restenosis.
Coats P; Kennedy S; Pyne S; Wainwright CL; Wadsworth RM
Atherosclerosis; 2008 Apr; 197(2):515-23. PubMed ID: 17662987
[TBL] [Abstract][Full Text] [Related]
2. Role of p44/p42 MAP kinase in the age-dependent increase in vascular smooth muscle cell proliferation and neointimal formation.
Gennaro G; Ménard C; Giasson E; Michaud SE; Palasis M; Meloche S; Rivard A
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):204-10. PubMed ID: 12588760
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD
J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
5. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
6. Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model.
Jandt E; Mutschke O; Mahboobi S; Uecker A; Platz R; Berndt A; Böhmer FD; Figulla HR; Werner GS
Vascul Pharmacol; 2010; 52(1-2):55-62. PubMed ID: 19951743
[TBL] [Abstract][Full Text] [Related]
7. Manumycin A, inhibitor of ras farnesyltransferase, inhibits proliferation and migration of rat vascular smooth muscle cells.
Kouchi H; Nakamura K; Fushimi K; Sakaguchi M; Miyazaki M; Ohe T; Namba M
Biochem Biophys Res Commun; 1999 Nov; 264(3):915-20. PubMed ID: 10544030
[TBL] [Abstract][Full Text] [Related]
8. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation.
Geraldes P; Sirois MG; Tanguay JF
Circ Res; 2003 Sep; 93(5):399-405. PubMed ID: 12893737
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
[TBL] [Abstract][Full Text] [Related]
10. Berberine inhibits platelet-derived growth factor-induced growth and migration partly through an AMPK-dependent pathway in vascular smooth muscle cells.
Liang KW; Yin SC; Ting CT; Lin SJ; Hsueh CM; Chen CY; Hsu SL
Eur J Pharmacol; 2008 Aug; 590(1-3):343-54. PubMed ID: 18590725
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
12. Ras/mitogen-activated protein kinase mediates norepinephrine-induced phospholipase D activation in rabbit aortic smooth muscle cells by a phosphorylation-dependent mechanism.
Muthalif MM; Parmentier JH; Benter IF; Karzoun N; Ahmed A; Khandekar Z; Adl MZ; Bourgoin S; Malik KU
J Pharmacol Exp Ther; 2000 Apr; 293(1):268-74. PubMed ID: 10734178
[TBL] [Abstract][Full Text] [Related]
13. The regulation of p42/p44 mitogen-activated protein kinases in the injured rat carotid artery.
Lille S; Daum G; Clowes MM; Clowes AW
J Surg Res; 1997 Jul; 70(2):178-86. PubMed ID: 9245569
[TBL] [Abstract][Full Text] [Related]
14. Role of Ras in ethanol modulation of angiotensin II activated p42/p44 MAP kinase in rat hepatocytes.
Park PH; Aroor AR; Shukla SD
Life Sci; 2006 Nov; 79(25):2357-63. PubMed ID: 16950409
[TBL] [Abstract][Full Text] [Related]
15. Peroxynitrite stimulates pulmonary artery endothelial and smooth muscle cell proliferation: involvement of ERK and PKC.
Agbani EO; Coats P; Mills A; Wadsworth RM
Pulm Pharmacol Ther; 2011 Feb; 24(1):100-9. PubMed ID: 20851205
[TBL] [Abstract][Full Text] [Related]
16. Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle.
Gosens R; Stelmack GL; Dueck G; McNeill KD; Yamasaki A; Gerthoffer WT; Unruh H; Gounni AS; Zaagsma J; Halayko AJ
Am J Physiol Lung Cell Mol Physiol; 2006 Sep; 291(3):L523-34. PubMed ID: 16617096
[TBL] [Abstract][Full Text] [Related]
17. Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1.
Hyvelin JM; Maurel B; Uzbekov R; Motterlini R; Lermusiaux P
J Vasc Surg; 2010 Feb; 51(2):417-28. PubMed ID: 20022212
[TBL] [Abstract][Full Text] [Related]
18. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
[TBL] [Abstract][Full Text] [Related]
20. Ras triggers acidosis-induced activation of the extracellular-signal-regulated kinase pathway in cardiac myocytes.
Haworth RS; Dashnyam S; Avkiran M
Biochem J; 2006 Nov; 399(3):493-501. PubMed ID: 16831126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
